BUNKER KEVIN D. (Chief Operating Officer) sold 6.3% of their position (10K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $469.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/10/2022ACC: 0001725160-22-000059
Officer· Chief Operating Officer
Since Apr 2020
-10K
Net shares
Net seller
$469.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
10K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−4K
Price / share
$46.23
Trade value
$184.94K
% of position
2.5%
3/10/2022
160K→156K
Common Stock
Indirect
Shares
−4.30K
Price / share
$47.18
Trade value
$202.90K
% of position
2.8%
3/10/2022
156K→151.70K
Common Stock
Indirect
Shares
−1.70K
Price / share
$47.99
Trade value
$81.54K
% of position
1.1%
3/10/2022
151.70K→150K
Total
Net shares
−10K
Net value
-$469.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/10/2022 | S · Sale | −4K | $46.23 | $184.94K | 2.5% | 160K | 156K |
| Common Stock Indirect | 3/10/2022 | S · Sale | −4.30K | $47.18 | $202.90K | 2.8% | 156K | 151.70K |
| Common Stock Indirect | 3/10/2022 | S · Sale | −1.70K | $47.99 | $81.54K | 1.1% | 151.70K | 150K |
| Total | −10K | -$469.37K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned350.00
Common Stock
DirectShares owned764.11K
Total
764.11K direct·350.00 indirect764.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 350.00 | Indirect |
| Common Stock | 764.11K | Direct |
| Total | 764.46K | 764.11K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported